-
Fears for global health R&D after US budget battle
Future research and development targeting diseases such as HIV, tuberculosis and malaria may be at risk because of across-the-board federal cuts implemented last year by the United States, the largest funder of global health R&D, warns a report.
- Categories
- Education, Health Care
-
Balancing Profits Against Public Health in the Search for Innovative Vaccines
There is no cure and no vaccine for the Ebola virus, which has killed about 70 people in Guinea. Vaccine expert Professor Adrian Hill tells DW why some vaccines take time. It's got to do with profit.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
US Global Health Research Funding Falls Short of Innovation Rhetoric
Despite the Obama administration's emphasis on science, technology, and innovation for international development, United States funding for global health research and development is not what it could or should be, according to an advocacy coalition of 30 global health nongovernmental organizations
- Categories
- Health Care
-
Drug-Resistant TB is Global Threat
The medical aid group -- Doctors without Borders -- warns that drug-resistant tuberculosis has become a global threat. It says despite the growing number of cases, there are no effective treatments.
- Categories
- Health Care
- Tags
- vaccines
-
Focus Heightens on Vaccine Preventable Diseases
Nigeria is better off preventing diseases than attempting cures on a continent with some of the highest disease burdens, say experts. This comes as the first indigenous vaccine manufacturer, Innovative Vaccines, launched in Nigeria.
- Categories
- Health Care
-
Weekly Roundup – 3/15/14: What it might take to change the mind of ‘vaccine truthers’
What if affluent "vaccine truthers" saw firsthand the reality of life in the developing world, where death and debilitating illnesses are the daily result of infectious diseases for which the prevention has been known for decades?
- Categories
- Education, Health Care
-
The quest for WHO prequalification by pharmaceutical firms
Annually, millions of patients in resource-limited countries receive life-saving medicines that are purchased by or through international procurement agencies such as World Health Organisation (WHO), United Nations Children Fund (UNICEF), United Nations Population Fund (UNFPA), UNITAID and the Global Fund to Fight AIDS, TB and Malaria.
- Categories
- Health Care
- Tags
- vaccines
-
Big Pharma still betting on “messed up” Indian drugs market
Global drugmakers have had a nauseous time in India's $14 billion market. Prices have dropped and valuable patents have been overruled as the authorities strive to make medicines affordable for the 70 percent of people living on less than $2 a day.
- Categories
- Health Care
- Tags
- governance, supply chains, vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.